EYA4 inhibits hepatocellular carcinoma by repressing MYCBP by dephosphorylating β‐catenin at Ser552

Hepatocellular carcinoma (HCC) is one of the most common malignancies and the fourth leading cause of cancer‐related death worldwide. Our previous study showed that EYA4 functioned by suppressing growth of HCC tumor cells, but its molecular mechanism is still not elucidated. Based on the results of...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Cancer Sci
Prif Awduron: Zhu, Xiao‐Xu, Li, Jian‐Hui, Cai, Jian‐Peng, Hou, Xun, Huang, Chen‐Song, Huang, Xi‐Tai, Wang, Jie‐Qin, Li, Shi‐Jin, Xu, Qiong‐Cong, Yin, Xiao‐Yu
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: John Wiley and Sons Inc. 2019
Pynciau:
Original Articles
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6778622/
https://ncbi.nlm.nih.gov/pubmed/31385398
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.14159
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg